Son Dakika
50% İndirim 0
📊 2025’de bizi neler bekliyor? İslam Memiş öngörülerini Investing.com’a özel yazısında paylaştı
Şimdi Okuyun
Kapat

Bny Mellon Large Cap Securities Inc (DREVX)

Alarm Oluştur
Yeni
Alarm Oluştur
Websitesi
  • Alarm bildirimi olarak
  • Bu özellikten faydalanabilmeniz için hesabınızda oturum açmış olmanız gerekmektedir
Mobil Uygulama
  • Bu özellikten faydalanabilmeniz için hesabınızda oturum açmış olmanız gerekmektedir
  • Aynı kullanıcı profili ile oturum açtığınızdan emin olun

Durum

Sıklık

Tek Seferlik
%

Sıklık

Sıklık

Bildirim Tipi

Durum

Portföy'e Ekle/Kaldır Portföye Ekle
Takip listesine ekle
Pozisyon Ekle

Pozisyon başarıyla eklendi:

Lütfen varlık portföyünüze isim verin
 
19,53 +0,19    +0,98%
24/12 - Geciken Veriler. Döviz USD
  • Morningstar Derecelendirmesi:
  • Toplam Varlık: 2,46B
Tür:  Fon
Piyasa:  ABD
İhraççı:  Dreyfus
Varlık Sınıfı:  Hisse senedi
Dreyfus Fund Incorporated 19,53 +0,19 +0,98%

DREVX Genel Bakış

 
Bu sayfada Bny Mellon Large Cap Securities Inc hakkında detaylı bir profile ulaşabilirsiniz. Yönetim, toplam varlıklar, yatırım stratejisi, iletişim bilgileri ve DREVX için diğer bilgileri görüntüleyin.
Kategori

Large Growth

Toplam Varlık

2,46B

Giderler

0,69%

Sözleşme Başlangıcı

18772

İrtibat Bilgisi

Adres 240 Greenwich Street
Manchester,NY M1 1RN
United Kingdom
Telefon -
Faks New York

Üst Düzey Yöneticiler

İsim Başlık B.Tarihi Bitiş
Julianne D. McHugh Portfolio Manager 2021 Şimdi
Biyografi Julianne is a senior portfolio manager and Newton’s head of sustainable equities. As an experienced investor, she has been integral in identifying resources to support and enhance the integration of sustainability considerations into the firm’s investment practices. Julianne manages a selection of global and regional equity mandates. She is the lead portfolio manager for the BNY Mellon Large Cap Securities Fund, leveraging the global research team to deliver capital growth by investing in high quality US companies with strong positions in their industries. Julianne has led the Emerging Markets Research Fund since its inception in February 2014. She also serves as a portfolio manager for Newton’s Global Research Equity and Global First Decade Innovators strategies. Julianne joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Julianne was a senior portfolio manager and senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Prior to joining BNY Mellon, Julianne was an equity analyst at State Street Research & Management. Julianne has a BS in Finance from Lehigh University and an MBA with a Financial Management track from MIT Sloan School of Management.
Karen Miki Behr - 2021 Şimdi
Biyografi Miki is a member of Newton’s equity opportunities team. In her current role, she is a portfolio manager on the growth funds. Miki joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Miki was a senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Previously, she was a research analyst with a focus on healthcare. Over her 14 years at the firm, she covered the consumer staples, consumer discretionary and healthcare sectors across EM, EAFE and the US. Prior to joining BNY Mellon, Miki worked at Leerink Swann & Co., a healthcare investment bank, advising venture capital and private equity firms as well as pharmaceutical, biotech and medical-device companies on strategic growth opportunities.
Matt Jenkin Senior Research Analyst 2020 2023
Biyografi Matt is a senior research analyst on The Boston Company's Global Research team, covering the health care sector. He has 15 years of health-care investing experience and almost five years of health-care industry experience. Matt has served as a health care portfolio manager and analyst at Balyasny Asset Management, Lehman Brokers/Barclays Capital and Bluecrest Capital Management, where he managed global long/short equity health-care hedge funds and covered pharmaceuticals, biotechnology and health-care services. He also worked at Dreyfus from 2001 to 2005, where he incepted and managed the 4-star Morningstar-rated Dreyfus Health Care Fund and maintained health-care sector research coverage. Earlier in his career, Matt was a senior research scientist at SmithKline Beecham, where he helped to develop cardiovascular/general surgical techniques, designed surgical models for MRI in stroke research, and researched osteoporosis. Matt earned a bachelor’s degree in biology from Tulane University and an M.B.A. from New York University.
Erik Swords Managing Director, Head of Global Technology 2019 2022
Biyografi Erik Swords is a head of global technology at Voya Investment Management. Prior to joining Voya, Erik was a lead portfolio manager and managing director at Allianz Global Investors, where he led the U.S. global technology team. Prior to that, he worked at Newton Investment Management for 16 years, leading one of BNY Mellon’s largest technology strategies, along with several other thematic portfolios focused on technology and related sectors. Previously, he worked as a research analyst covering the software sector at Pilgrim Baxter Associates, Exis Capital Management, and Credit Suisse First Boston Technology Group. Erik earned a BS in finance from Lehigh University.
Leigh N. Todd Managing Director 2015 2021
Biyografi Ms. Todd is a managing director and senior research analyst at Mellon Investments Corporation ("Mellon") and joined Mellon's predecessor company in 2005. She was previously employed by Dreyfus, and affiliated BNY Mellon company, since 2001. Prior to that, she was employed by State Street Global Advisors.
Robin Wehbe Director 2019 2020
Biyografi Robin Wehbe, CFA, CMT, is a director and equity research analyst at The Boston Company Asset Management, LLC (TBCAM), an affiliate of Dreyfus, where he has been employed since July 2006. He is a research analyst on TBCAM’s core research team, covering the energy, utilities and basic materials sectors. Prior to joining TBCAM, he was employed with State Street Global Advisors since 2003, most recently as a global research analyst, covering the basic materials sector. He also has been employed by Dreyfus since January 2009.
Barry K. Mills Lead Portfolio Manager 2010 2019
Biyografi Mills is a portfolio manager and senior managing analyst with Drefyus, his employer since 1999. Prior to joining the firm, he served as a portfolio manager with Phoenix Funds. From 1995-February 1997, he served as Director of Research for Howe and Rusling, Inc.
David M. Sealy Portfolio Manager 2010 2019
Biyografi Sealy is a portfolio manager at Dreyfus. He is a vice president, portfolio manager and research analyst at The Boston Company Asset Management, LLC, an affiliate of Dreyfus, where he has been employed since June 2005. He also has been employed by Dreyfus since May 1997.
Elizabeth Slover Director/ Portfolio Manager 2015 2019
Biyografi Elizabeth is the Director of The Boston Company’s Global Research Team, overseeing research for the U.S., EAFE and Emerging Markets. Elizabeth is also a Portfolio Manager on the US Large Cap Growth Equity strategy. Before joining The Boston Company, Elizabeth was with Chancellor LGT Asset Management (now Invesco), where she worked for the Director of Equities, responsible for managing the Equity Research Group. Before joining Chancellor, Elizabeth was in the Equity Research Department of Smith Barney, where she worked for the Chief Investment Strategist. She received a BA in Political Science from Union College.
Sean P. Fitzgibbon - 2005 2015
Biyografi Sean P. Fitzgibbon, CFA Executive Vice President, Senior Portfolio Manager Sean is the lead portfolio manager for the firm's Thematic Active Equity and Emerging Markets Equity strategies. Previously, he worked in research, covering Health Care, Consumer Discretionary, Consumer Staples, Financials and Utilities. Sean received a BS in economics from Northeastern University and an MBA from Babson College. He holds the CFA® designation and is a member of the CFA Institute and the CFA Society Boston.
Yorum Kuralları

Yorumları kullanarak diğer kullanıcılarla bağlantıya geçebilir, görüşlerinizi paylaşabilir, yazarlara ve diğer kullanıcılara sorular sorabilirsiniz. Ancak, söylem düzeyini yüksek tutmak amacıyla oluşturduğumuz aşağıdaki kriterlere lütfen uyunuz:

  • Söyleşiyi zenginleştirin.
  • Bağlamı koruyun. Sadece tartışılan konuyla ilgili bilgileri gönderin.
  • Saygılı olun. Eleştirel görüşler, pozitif ve diplomatik bir üslupla anlatılabilir.
  • Standart yazı stili kullanın. Noktalama, küçük ve büyük harf kullanın, imla kurallarına uyun.
  • Spam veya reklam mesajı atmak yasaktır.
  • Küfür, argo kullanımı yasaktır.
  • Sadece Türkçe yorum yapabilirsiniz.

Spam mesajlar yazan, argo/küfür kullanan ve forumu suistimal eden kullanıcıların hesapları süresiz olarak kapatılacaktır.

DREVX Yorumları

Bny Mellon Large Cap Securities Inc hakkında düşüncelerinizi yazın
 
Bu grafiği silmek istediğinize emin misiniz?
 
Gönder
Bu sayfada da paylaş:
 
Ekteki grafiği yeni bir grafikle değiştirmek istiyor musunuz?
1000
Yorum yapma yetkiniz olumsuz puanlama sebebiyle kısıtlanmıştır. Durumunuz moderatörlerimiz tarafından incelenecektir.
Lütfen tekrar yorum yapmadan önce bir dakika bekleyiniz.
Yorumunuz için teşekkür ederiz. Yorumunuz, yöneticilerimiz tarafından kontrol edildikten sonra onaylanacaktır. Bu sebeple yorumunuzun yayınlanması biraz zaman alabilir.
 
Bu grafiği silmek istediğinize emin misiniz?
 
Gönder
 
Ekteki grafiği yeni bir grafikle değiştirmek istiyor musunuz?
1000
Yorum yapma yetkiniz olumsuz puanlama sebebiyle kısıtlanmıştır. Durumunuz moderatörlerimiz tarafından incelenecektir.
Lütfen tekrar yorum yapmadan önce bir dakika bekleyiniz.
Yoruma Grafik Ekle
Engellemeyi Onayla

%USER_NAME% isimli kullanıcıyı engellemek istediğinize emin misiniz?

Bunu onayladıktan sonra %USER_NAME% isimli kullanıcı ile birbirinizin yorumlarını görmeyeceksiniz.

%USER_NAME% başarıyla Engelli Listesine eklendi

Bu kişinin engelini yeni kaldırdınız. Yeniden engellemek için 48 saat beklemeniz gerekmektedir.

Yorumu şikayet et

Yorum silinmeli, çünkü:

Yorum Şikayet Edildi

Teşekkürler!

Şikayetiniz yönetim ekibimize iletildi
Apple ile Devam Et
Google ile Kayıt Ol
veya
E-posta ile Kayıt Ol